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Aggrecan, link protein and tenascin-R are essential
components of the perineuronal net to protect neurons
against iron-induced oxidative stress
A Suttkus1, S Rohn1, S Weigel1, P Glöckner1, T Arendt*,1 and M Morawski1,2
In Alzheimer’s disease (AD), different types of neurons and different brain areas show differential patterns of vulnerability
towards neurofibrillary degeneration, which provides the basis for a highly predictive profile of disease progression throughout
the brain that now is widely accepted for neuropathological staging. In previous studies we could demonstrate that in AD cortical
and subcortical neurons are constantly less frequently affected by neurofibrillary degeneration if they are enwrapped by a
specialized form of the hyaluronan-based extracellular matrix (ECM), the so called ‘perineuronal net’ (PN). PNs are basically
composed of large aggregating chondroitin sulphate proteoglycans connected to a hyaluronan backbone, stabilized by link
proteins and cross-linked via tenascin-R (TN-R). Under experimental conditions in mice, PN-ensheathed neurons are better
protected against iron-induced neurodegeneration than neurons without PN. Still, it remains unclear whether these
neuroprotective effects are directly mediated by the PNs or are associated with some other mechanism in these neurons
unrelated to PNs. To identify molecular components that essentially mediate the neuroprotective aspect on PN-ensheathed
neurons, we comparatively analysed neuronal degeneration induced by a single injection of FeCl3 on four different mice
knockout strains, each being deficient for a different component of PNs. Aggrecan, link protein and TN-R were identified to be
essential for the neuroprotective properties of PN, whereas the contribution of brevican was negligible. Our findings indicate that
the protection of PN-ensheathed neurons is directly mediated by the net structure and that both the high negative charge and the
correct interaction of net components are essential for their neuroprotective function.
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Cell death in the nervous system, irrespective of whether it is
caused by inflammation, ischaemia or primary degeneration,
selectively affects rather constantly special types of neurons,
whereas others are spared even under advanced disease
conditions. AD represents one of the best-characterized
paradigms for this principle of ‘selective neuronal vulner-
ability’. Here, different types of neurons and different brain
areas show a differential pattern of vulnerability towards
neurofibrillary degeneration, which provides the basis for a
highly predictive profile of disease progression throughout the
brain, which now is widely accepted for neuropathologically
staging.1 In previous studies we could demonstrate that in AD
cortical and subcortical neurons are constantly less frequently
affected by neurofibrillary degeneration if they are enwrapped
by a specialized form of the ECM, the so-called PN.2,3 Recent
studies identified another stable form of ECM in the central
nervous system. Those small, round or oval structures, called
axonal coats, are mostly found to surround synaptic sites on
dendrites and cell bodies.3–7
PNs are large meshworks surrounding neuronal cells
composed of ECM molecules, which after their first descrip-
tion in the 1890s by Golgi and Ramón Y Cajal were largely
neglected and re-discovered only around 30 years ago.8–10
PNs are composed of chondroitin sulphate proteoglycans
(CSPGs), including lecticans (aggrecan, brevican, neurocan
and versican), phosphacan and hyaluronan, TN-R and link
proteins (cartilage link protein Crtl-1/HAPLN-1 and brain link
protein Bral2/HAPLN-4).11–14 These components interact
with each other and with hyaluronan, which provides the
molecular backbone of the PN, thereby creating a stable
scaffold around cell bodies and proximal dendrites of
neurons15,16 (for the principal structure of PN in the barrel
field cortex see Figure 1a).
The role of the PN is not completely understood. Different
functions have been suggested derived from the functional
properties of their molecular constituents. PNs contain both
CSPGs and TN-R, known to inhibit neurite outgrowth, and
may thus result in a restriction of neuronal and synaptic
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plasticity.9,17,18 In addition, the glycoprotein components of
the PNs carry numerous glycosaminoglycan (GAG) side
chains, which are long unbranched polymers of repetitive
disaccharide units consisting of an amino-sugar (N-acetylga-
lactosamine).19 Sulphate groups attached to these GAGs in
concert with the negatively charged hyaluronic acid generate
a highly polyanionic microenvironment around PN-
ensheathed neurons.20,21 Most likely, they can, thus, interact
with calcium, potassium and sodium ions, providing a local
‘buffer reservoir’ for physiologically relevant cations. In
cortical areas, PN-wearing interneurons are often associated
with the calcium-binding protein parvalbumin (PV). These
interneurons are identified as highly active and fast
spiking, which requires high ionic currents and a tightly
regulated ion homeostasis. The anionic features of PNs
surrounding these neurons might contribute to meet these
requirements.20,22–25
In addition to this physiological mechanism, the polyanionic
components might also interact with ions of potential
pathophysiological relevance such as iron ions involved in
generating oxidative stress.20,22,26,27 We have, thus, put
forward the hypothesis that PNs, through scavenging and
binding of redoxactive iron, are able to reduce the potentially
deleterious local oxidative potential in the neuronal micro-
environment, thereby protecting neurons ensheathed by PNs
against oxidative damage.22,28 In support of this suggestion,
we previously observed that both in normal-aged brain and
AD neurons ensheathed by a PN are less frequently affected
by lipofuscin accumulation than neurons without a net.
As lipofuscin is an intralysosomal pigment composed of
cross-linked proteins and lipids generated by iron-catalysed
oxidative processes, this finding suggests a neuroprotective
function of PNs against neurodegeneration induced by
oxidative stress.22,23,29–31 In an effort to validate our
hypothesis, we analysed the effects of iron injection into
mice brain on neurons with or without PN. We could show
that net-associated neurons were less severely affected
by degeneration than neurons without PNs.28 Still, it
remains unclear whether these neuroprotective effects are
directly mediated by the PN or its components are associated
with some other mechanism in these neurons unrelated
to PNs.
Therefore, in the present study, we intended, first, to verify
that PNs are directly involved in the neuroprotective mechan-
ism and second, to identify those molecular components of
PNs that essentially mediate these neuroprotective proper-
ties. To this end, we comparatively analysed the sequalae of
iron-induced neuronal damage in four different mice knockout
strains, each deficient for a different molecular component of
the PN, such as aggrecan (ACANþ / ), brevican (BCAN / ),
tenascin-R (TN-R / ) or link protein 1 (HAPLN1 / ). (for the
principal structure of PNs in the used mouse models see
Figures 1b–e). We could identify aggrecan, tenascin and link
protein HAPLN1 as PN components essential to mediate their
Figure 1 Schematic synopsis of molecular composition of PNs in the barrel field cortex. (a) Hyaluronan synthases are located at the neuronal surface, synthesizing and
secreting hyaluronan to the perineuronal area. Members of the lectican family (aggrecan, neurocan and brevican) bind to this hyaluronic backbone. So far, versican could not
be identified as part of PN in the barrel field cortex. Binding of CSPGs to hyaluronan is stabilized by the link proteins. TN-R crosslinks the lecticans to form stable PNs. (b) PNs
of heterozygous deficient aggrecan mice (ACANþ / ) lacking about 50% of the originally included aggrecan. (c) In mice lacking brevican (BCAN / ), neurocan partially
compensates for it. (d) PNs of mice lacking link protein (HAPLN1 / ) or TN-R / (e) are structured loosely, preventing the formation of stable meshworks
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neuroprotective properties. These results clearly show a
direct albeit differential contribution of ECM components to
the neuroprotective function of PNs.
Results
In the present study, we analysed whether the neuroprotec-
tive properties associated with the presence of PN, previously
observed,28 are directly mediated by the PN or whether the
PN only provides a surrogate marker of some unidentified
mechanism. Further, we defined the molecular components of
the PN that are essential to mediate these neuroprotective
properties. To this end, protection of PN-ensheathed neurons
was differentially analysed after microinjection of FeCl3 into
the barrel field cortex, in four different mice knockout strains,
each being deficient for a different component of PNs, such as
aggrecan (ACANþ / ), lacking brevican (BCAN / ), link
protein (HAPLN1 / ) or tenascin-R (TN-R / ) knockout mice.
PN-associated phenotypes of different mice knockout
strains. The constitutive deficiency of defined molecular net
components had some phenotypic effects on the appearance
but not on the number of PNs in all tested mouse strains. The
phenotypic appearance of PNs in mice either lacking
brevican (BCAN / ) or being deficient in aggrecan
(ACANþ / ) did not differ noticeably from wild type, enwrap-
ping the neuronal soma as well as the proximal dendrites as
a sharply contoured, lattice-like meshwork. PNs of mice
lacking link protein (HAPLN1 / ) or tenascin-R (TN-R / )
in contrast appeared somewhat more fuzzy and granular with
reduced staining around dendrites (Figures 2a–e). Similar
observations were made previously.13,32–34
To determine whether the deficiency of defined molecular
components of PNs had a constitutive effect on the number of
PNs, we assessed the numerical density of neurons with and
without PN in the barrel field cortex of each different mouse
knockout strain (Figures 2a1–e1). There were no effects on
the total numerical density of neurons in any of the knockout
strains compared with wild type.
Next, we analysed whether different knockout genotypes
had any effects on the number of neurons enwrapped by PNs.
In addition, PN-associated neurons were stratified according
to the presence or absence of PV. In wild-type animals,
PN-ensheathed neurons amounted to about 10% of all
neurons, with about half of them (49%) containing PV. This
was in accordance with Nowicka et al.35 The lack of brevican
as well as the deficit of aggrecan had no effects on the
presence of PN-ensheathed neurons. In contrast, net-
associated neurons as well as net-associated PV positive
neurons were significantly reduced in number in HAPLN1 /
and TN-R / mice. The ratio of PN-associated neurons with
and without PV was only shifted in TN-R / mice, with a
significant reduction of PV containing PN-ensheathed
neurons.
Knockout genotypes of PN-associated components
have differential effects on brain lesions. To define
molecular components, essential to mediate the neuropro-
tective properties of PNs, we investigated the effects of
deficiency of a defined PN component on the size of
experimentally induced brain lesion. After injection of FeCl3
into the barrel cortex, a widespread degeneration of brain
tissue was observed around the injection site in all mice
strains, which could clearly be delineated by Fluoro-Jade B
staining (Figures 3a–e). Quantification of the lesion size,
however, clearly showed that all transgenic mice strains
showed significantly larger degeneration than wild-type mice
(Figure 3f). A lack of tenascin-R (TN-R / ) mediated the
most extensive degeneration with a radius of about 1500 mm
of the affected cross-sectional area. Somewhat smaller
dimensions of degeneration were observed in mice lacking
link protein 1 (HAPLN1 / ), aggrecan (ACANþ / ) or
brevican (BCAN / ) with average radii of the lesion
between 1300 and 1350 mm. However, no significant
differences could be measured. Control injections with
0.9% NaCl revealed only marginal lesions with maximum
degeneration radii of 200mm (data not shown). Again, no
significant differences could be investigated within the
different mice strains or in comparison to WT mice.
Aggrecan, TN-R and link protein 1 are essential for the
neuroprotective properties of PNs. Next, we analysed in
our lesion paradigm whether neurons ensheathed by a PN
lacking a specific matrix compound were affected differen-
tially compared with neurons without PN. To this end, we
labelled the net structure either with Wisteria floribunda
agglutinin (WFA), which binds to chondroitin sulphate side
chains most likely on aggrecan,36–38 or with an antibody that
labels the aggrecan core protein (HAG), the main proteogly-
can component of PNs.4,10,18,39
Three independent methods were used to detect degen-
erating neurons, namely Fluoro-Jade B staining, a caspase-3
antibody and an antibody against H2AX in combination with
histochemical labelling of the net structures. The vast majority
of degenerating neurons, detected with any of these methods,
were devoid of PNs (Figure 4). Only occasionally, PN-
ensheathed neurons were positive for a stain detecting
degenerating neurons. Still these rare cases, as exemplified
in Figure 4, clearly ruled out any systemic bias with respect to
accessibility of the detection dye to neurons ensheathed by
PN compared with neurons without PN.
To obtain a quantitative measure on the effects of PNs upon
neurodegeneration, degenerating neurons were quantified
after a combination of PN labelling by either WFA histochem-
istry or anti-HAG immunocytochemistry with Fluoro-Jade B
and NeuN (Figure 5).
In Figures 6a–e the percentage of Fluoro-Jade B-positive
neurons without PN (light grey), in regard to the total number
of neurons without PN, is compared with the percentage of
Fluoro-Jade B-positive neurons with a PN (dark grey), relating
to the total number of neurons ensheathed by a PN.
The results of cell counting revealed clear differences for
affected neurons, depending on the knockout mice strain. In
brevican knockout mice (BCAN / ), PN-associated neurons
were significantly less frequently affected by degeneration
than neurons without PN. This effect was independent of the
detection method of PNs (Figure 6c). In aggrecan-deficient
mice (ACANþ / ), neurons ensheathed by a PN, visualized
with WFA, were also less frequently affected by degeneration
compared with neurons without PN (Figure 6b). This difference
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disappeared, however, when aggrecan immunocytochemis-
try (HAG) was used for detection of PNs. Differences in
vulnerability between neurons with and without PN were
abolished completely in mice lacking either the
link protein 1 (HAPLN-1 / ) (Figure 6d) or tenascin-R
(TN-R / ) (Figure 6e).
To evaluate any potential contribution of PV to the
neuroprotective properties on PN-ensheathed neurons,
triple-stained sections, labelled for PV and Fluoro-Jade B in
combination with either HAG or WFA were analysed likewise
for differential effects of degeneration. As summarized in
Figures 6a1–e1, no increased protection of PV-associated
net-wearing neurons could be observed. In BCAN / mice,
PN-associated neurons with PV detected by WFA as well as
HAG were even significantly more frequently affected than
those without PV.
Figure 2 Morphological and numerical appearance of neurons with and without PN in different mice knockout strains compared with wild type, detected in layers II and III
of the barrel field cortex. Double fluorescence staining of PNs by WFA (pink) and the Ca-binding protein PV (green). Sections of wild-type mice (a) show intensely labelled,
robust lattice-like structures enwrapping the neuronal soma and the proximal dendrites; PN of mice deficient for aggrecan (ACANþ / ) (b) or brevican (BCAN / ) (c) look
slightly fuzzy, but not disturbed. In contrast, PN of mice lacking the cartilage link protein (HAPLN1 / ) are attenuated and disturbed with almost no staining around dendrites.
(d) Furthermore, Tenascin-R (TN-R / ) knockout mice (e) display granular structures with lesser overall staining around dendrites. (a1–e1) Numerical density of neurons
stained by NeuN (dark grey), of PN-associated neurons detected by (WFA, light grey) or an antibody against aggrecan core protein (HAG, light grey) and of
PN-associated neurons expressing PV (white) in the barrel field cortex. In mice deficient for aggrecan (b1), link protein 1 (d1) or TN-R (e1), numbers of PN-associated as well
as PN-associated, PV-expressing neurons were significantly reduced. The lack of brevican (c1) had no effect on the numerical density of neurons. Data are mean values,
±S.D. Statistical analysis by Mann–Whitney test, n¼ 5. *Po0.05, scale bar 20mm
Figure 3 Extent of neurodegeneration induced by single-sided injection of FeCl3 into the barrel field cortex of mice knockout strains lacking specific components of PNs.
(a–e) Typical examples of coronal sections cut through the lesion at its maximal extension. A volume of 0.2ml 20 mM FeCl3 was injected into the left barrel field cortex;
degenerating cells were detected by Fluoro-Jade B staining 24 h later. Note that brain tissue volume affected by degeneration is significantly different in different mice strains.
(a) WT; (b) ACANþ / ; (c) BCAN / ; (d) HAPLN-1 / , (e) TN-R / . Scale bar 500mm. Quantification of lesion size determined on serial sections after staining with
Fluoro-Jade B (f). In all mice knockout strains, lesion size was significantly larger than in wild type (WT). A lack of tenascin (TN-R / ) results in the most extensive spreading
of degeneration. In brevican knockout mice (BCAN / ), heterozygous aggrecan knockout mice (ACANþ / ) and mice lacking the link protein 1(HAPLN-1 / ), lesion size
is somewhat smaller. Data are expressed as mean values. Statistical analysis by Mann–Whitney test, n¼ 5. *Po0.05
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Aggrecan is upregulated after FeCl3 induced injury. In
addition, we investigated the aggrecan expression in the
injured CNS by western blotting. For this analysis, the
hemisphere of iron-induced lesion as well as the correspon-
dent contralateral hemisphere were dissected and prepared
for subsequent processing. Protein extracts were run in a 6%
gel. Western blot analysis with the anti-aggrecan antibody
AB1031 revealed a single band at B450 kDa in injured and
uninjured hemispheres (Figure 7a). A comparative quantifi-
cation with TINA software (Raytest, Straubenhardt, Germany)
revealed higher contents of aggrecan in iron-injected
hemispheres for all tested mouse lines, with significant
differences in mice lacking brevican or HAPLN1 (Figure 7b).
Here, the content of aggrecan is increased by 45% (BCAN / )
and 67% (HAPLN1 / ). Furthermore, a significant decrease
of aggrecan in mice heterozygous deficient for aggrecan
(ACANþ / ) could be confirmed. Here, the overall content of
aggrecan is reduced by 60% compared with the analysed
tissue of WT mice.
Discussion
In the present study, we defined molecular components of
PNs that essentially mediate neuroprotective properties.
Using a comparative approach, provoking a neurotoxic insult
in four different transgenic mice strains, each lacking or being
deficient in a different molecular component of PNs, we could
identify clear differences with respect to both lesion size and
neuronal population affected by degeneration. Neurons
ensheathed by a PN in wild-type mice were less frequently
affected by degeneration than neurons without PN. These
neuroprotective properties associated with the presence of
PNs were lost when TN-R and HAPLN-1 were lacking, while
the deficiency of aggrecan had a partial effect and the lack of
brevican had no effect.
In addition, mice deficient for TN-R, link protein 1, brevican
or aggrecan showed a significantly higher spreading of
degeneration than wild-type mice after single sided injection
of FeCl3. This increase in tissue volume, which is affected by
degeneration, was observed for all mice strains lacking a
specific matrix component. On the background of previous
reports on the contribution of lecticans40,41 and TN-R42 to the
diffusion and hydration properties of the neural ECM, a
facilitated diffusion of dissociated FeCl3 due to the lack of PN
components most likely accounts for these effects.
Our main interest was the identification of hyaluronan-
based ECM molecules, which essentially mediate the
neuroprotective properties of PNs. Aggrecan is one of the
main components of the ECM and the key component of the
PNs.43,44 It is the largest member of the lectican family and
carries up to 100 negatively charged chondroitin sulphate side
chains.10,45 Thus, aggrecan interacting with hyaluronan, also
highly negatively charged, mainly contributes to the poly-
anionic character of the PN. Our data show that PN detected
by the aggrecan antibody HAG in mice heterozygous deficient
for aggrecan (ACANþ / ), have lost their neuroprotective
properties. Most likely, the content of aggrecan in these PNs is
reduced below a critical level, which is not sufficient to exert
Figure 4 Different detection methods for neuronal death in the barrel field cortex. Degenerated cells after injection of FeCl3 can be visualized with Fluoro-Jade B (a), an
active caspase-3 antibody (b) and an antibody against H2AX (c). All three markers visualize degenerated cells to a similar extent. A microscopic picture with a higher
magnification of the different markers (a1–c1), followed by the combination with WFA histochemistry (red) and the neuronal marker NeuN (pink) (a2–c2) allows a
determination of affected neurons with and without PN. Scale bar (a–c) 500 mm and (a1–c2) 20 mm
Essential components of the perineuronal net to protect neurons
A Suttkus et al
6
Cell Death and Disease
the neuroprotective effects.44 Neurons with PNs, however,
detected in the same mice with WFA were significantly less
frequently affected by iron-induced degeneration. This might
indicate that other matrix compounds providing binding sites
for WFA might partially compensate for the loss of aggrecan.
In addition, it might show that WFA binding, indicating the
presence of highly charged anionic binding sites, provides a
signature for the neuroprotective properties of PNs. The
hypothesis that aggrecan is one of the key factors for
mediating neuroprotective properties is supported by the data
received from the western blotting analysis. Here, the
decreased level of aggrecan in ACANþ / mice in comparison
with WT mice could be demonstrated. Furthermore, the
content of aggrecan in the hemisphere containing the iron
injection is increased compared with the not-injected hemi-
sphere in all mouse lines. Here, significant differences could
be shown for mice lacking brevican and link protein HAPLN1.
However, this clear trend could confirm a certain neuroprotec-
tion of aggrecan itself. An upregulation of aggrecan could
already be seen in studies concerning neurodegenerative
diseases. Lendvai et al.7 could demonstrate increased
aggrecan contents in the hippocampal formation of AD
patients as well as in the hippocampal tissue of the AD
mouse model APPswe/PS1dE9.7 They suggested that this
upregulation of aggrecan could be based on neuroprotective
mechanisms. An upregulation of PN components has so far
been shown only for versican and neurocan in the context of
forming a glial scar after brain injury.14 However, versican and
neurocan most likely do not contribute to neuroprotective
mechanisms, but rather to the inhibition of axonal outgrowth
and regeneration, respectively. So, aggrecan represents the
most potential CSPG in the context of protective processes.
Another proteoglycan component we investigated is brevi-
can. Here, brevican showed the smallest contribution to
neuroprotective features of PNs, if any. This could be
demonstrated irrespectively of whether the remaining net
was detected by WFA binding sites or HAG. Brevican is an
important proteoglycan in the adult rodent and to some extent
part of the PN. It is mainly enriched in the perisynaptic
structure of the axonal coats while it contributes only margin-
ally to enwrapping of the neuronal soma (unpublished results).
Brakebusch et al.32 could demonstrate a certain upregulation
of neurocan in brevican knockout mice, which may partially
compensate for the loss of brevican. But, the expression of
neurocan, highly upregulated during embryonic development,
indicates a strong influence of neurocan mainly during early
Figure 5 Detection of death neurons with and without PN in different mice knockout strains detected by triple staining. PNs were visualized by HAG (red), degenerating
cells were labelled by Fluoro-Jade B (green) and neurons were detected by NeuN (pink). Merged images were used for quantitative analysis. Scale bar 20 mm
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developmental processes. Brevican, however, is highly
expressed during the formation of PNs until the end of the
critical period. Neurocan and brevican have a largely
complementary expression profile during ontogenesis. Thus,
it is assumable that the upregulation of neurocan in BCAN /
mice beyond embryonic development may be in order to
reduce developmental deficits. So, it is comprehensible that
the loss of brevican does not have a major effect on the
‘shielding’ properties of PNs against oxidative damage.46–48
The next matrix component we have analysed is the link
protein HAPLN-1. HAPLN-1, next to HAPLN-4, stabilizes the
interaction between hyaluronan and CSPGs by binding to
both components.49 Of the several PN elements, HAPLN1
starts to be expressed exactly at the time PNs begin to
develop. So, it might be a trigger for PN development.
Furthermore, animals lacking HAPLN-1 do not form normally
shaped PNs. PNs of HAPLN1 knockout mice are diffuse and
seem to be less close to the plasma membrane than those of
wild-type mice.13 Our experiments show that PNs lacking
HAPLN1 have completely lost their neuroprotective proper-
ties. HAPLN1, thus, represents a matrix component that is
essential for this function of PNs.
Results obtained on mice lacking tenascin-R (TN-R / )
were similar to those of HAPLN-1 / mice. As a large ECM
glycoprotein, TN-R participates in macromolecular organiza-
tion of PNs.50 It interacts with the cell surface as well as with
CSPGs, including aggrecan, versican, neurocan and, with
highest affinity, brevican.51 While the general histology
appeared to be unaffected in TN-R-deficient mice, changes
were observed in the shape and appearance of PNs, like in the
HAPLN-1 knockouts. They showed a reduced WFA-staining
intensity and were characterized by a more granular and less
punctuate structure.33 In addition, these alterations were
accompanied by a reduction of immunohistochemical staining
intensity in other major matrix components, such as hyalur-
onan, neurocan, brevican and phosphacan.34 Altogether,
these structural and molecular changes of the ECM might
directly affect the physiology of neurons. This includes a
disturbed synaptic stability as well as an inefficient main-
tenance of the ionhomeostasis .52 Our present data show
that TN-R is also essential for the neuroprotective properties
of PNs.
In summary, our findings indicate that the different ECM
components of PNs contribute differently to their protective
Figure 6 Neuronal degeneration after injection of FeCl3 into the barrel field cortex separately quantified for neurones with and without PN, respectively, for the presence or
absence of PV. PNs were visualized by either anti-HAG immunocytochemistry (left) or WFA lectin histochemistry (right). In WT mice (a), PN-associated neurons are
significantly protected compared with neurons without PN. This difference can still be detected in mice lacking brevican (BCAN / , c), but is somewhat attenuated in
heterozygous aggrecan (ACANþ / , b) knockout mice. The protective effect of PNs, however, is completely abolished in mice lacking the link protein (HAPLN1 / , d) or
tenascin-R (TN-R / , e). Comparing PN-associated neurons without PV to PN-associated neurons with PV reveals no contribution of PV to the neuroprotective function of
PN. Brevican knockout mice (c1) indicate an even less severe affection of PN-wearing neurons without PV. No significant differences were obtained on wild-type mice (a1),
heterozygous aggrecan knockout mice (b1), mice lacking the link protein (d1) or TN-R (e1). Data are expressed as mean values. Statistical analysis by Wilcoxon rank test,
n¼ 5. *Po0.05, **Po0.01, ***Po0.001
Figure 7 Western blot analysis of aggrecan contents. Protein extracts (30mg/lane) from homogenized neuronal sections from the ipsilateral site of injection were
compared with the contralateral control site. Samples were subjected to SDS PAGE in a 6% gel. Blots were probed by use of an antibody against aggrecan (AB1031) (a).
Mean±S.D. intensity of chemiluminescence was quantified for bands at 450 kDa (b) in relation to the bands of HSP90. An upregulation of aggrecan was evident with
significant increases in BCAN / and HAPLN1 / mice. Statistical analysis by Mann–Whitney test, n¼ 4. *Po0.05
Essential components of the perineuronal net to protect neurons
A Suttkus et al
9
Cell Death and Disease
properties. Brevican plays no direct part in protecting cells
against iron-induced cell death. However, a contribution to
diffusion properties is likely. On the contrary, aggrecan as the
main proteoglycan component seems to be essential for
protection against iron-induced cell death. Aggrecan is
besides hyaluronan in charge of imparting the PN, a
polyanionic character.45 This highly negative charge could
be the main aspect of the protective feature. This assumption
is supported by our observation that even in heterozygous
aggrecan-deficient mice the neuroprotective properties are
still preserved in those PNs where sufficient negatively
charged chondroitin sulphate side chains are present to
generate a WFA binding.53
Further, our data indicate that the two matrix components,
HAPLN1 and TN-R, are also essential for the neuroprotective
function of PNs. HAPLN1 consolidates the binding of CSPGs
to hyaluronan.13 Therefore, a strong connection of the CSPGs
to hyaluronan seems to be an essential factor. Similar
evidence was received from analysing TN-R / mice. This
leads to the assumption that TN-R, by way of forming stable
aggregates, has a relevant part in mediating a protective
aspect of the PNs.
Conclusion
Taken together, our findings indicate that the neuroprotection
of neurons ensheathed by a PN against iron-induced cell
death is directly mediated by the PN and that both the high
negative charge and the correct interaction of net components
to form a stable barrier against ions are essential factors for
their neuroprotective properties.
Materials and Methods
Animals. The following mouse lines were used in the present study: C57BL/6J
mice, heterozygote aggrecan-deficient (ACANþ / ) mice were obtained from
Prof. Dr. RT Matthews (State University of New York, Upstate Medical University,
Syracuse, NY, USA);36,43,54 brevican knockout mice (BCAN / ) mice were
obtained from Dr. C Seidenbecher (Leibniz Institute for Neurobiology, Magdeburg,
Germany);32,55 TN-R knockout mice (TN-R / ) were obtained from Prof. Dr.
M Schachner (Center for Molecular Neurobiology Hamburg (ZMNH), University of
Hamburg, Germany);33,34 and link protein-deficient (HAPLN1 / ) mice were
obtained from Prof. Dr. J Fawcett (MRC Brain Repair, University of Cambridge,
UK) and Prof Dr. T Pizzorusso (Instituto Neuroscienze CNR, Pisa, Italy).13,56 Male
and female mice were bred and housed at the Medizinisch-Experimentelles
Zentrum of the Medical Faculty of the University of Leipzig. Animals had free
access to food and water and were maintained on an artificial 12 : 12-h light–dark
cycle under conditions of constant temperature (22 1C) and humidity. All
experimental procedures on animals were carried out in accordance with the
European Council Directive of 24 November 1986 (86/609/EEC) and had been
approved by the local authorities (TVV50/10).
In vivo injection. Mice at an age of 3 months were deeply anaesthetized by
intraperitoneal injection with a cocktail of ketamine (100 mg/kg, ratiopharm, Ulm,
Germany) and xylazine (5 mg/kg, Rompun, Bayer, Germany). Animals, fixed to a
stereotaxic apparatus (Stoelting, Wood Dale, IL, USA), received injections of 0.2ml
20 mM FeCl3 dissolved in a 0.9% NaCl solution over 10 min at AP  1.7 mm,
Lþ / 3 mm, V  2 mm (from bregma and dura, head flat between bregma and
dura; somatosensory cortex, barrel field S1BF according to Paxinos and
Franklin57) using a 33-gauge needle (33/51/4, Hamilton) attached to a Hamilton
syringe (Type 75-RN, Switzerland). Five animals per group were used. Animals of the
control group received an equal volume of 0.9% NaCl, which was adjusted to the pH 4
analogue to the FeCl3 solution (n¼ 3). Animals were analysed 24 h post injection.
Tissue preparation. Animals were perfused transcardially under deep CO2
anaesthesia with 0.9% NaCl and 4% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS). Animals were decapitated; brains were removed
immediately, fixed in 4% buffered PFA (24 h) and cryoprotected in 30% sucrose
with 0.01% sodium azide in PBS (48 h). Series of coronal sections were cut on a
freezing microtome at 30mm thickness and collected in PBS with 0.01% sodium
azide.
Detection of cellular death. Degenerated neurons were detected by three
different methods: staining sections with (i) Fluoro-Jade B (0.001%, Chemicon,
Temecula, CA, USA), using an (ii) anti-caspase-3 antibody (AB3623, 1 : 50,
Millipore, Darmstadt, Germany) or an (iii) antibody against phosphoS139 H2AX, a
well-established marker for double-stranded DNA breaks (ab2893, 1 : 50, Abcam,
Cambridge, UK).58 To clearly distinguish between degeneration of neurons
ensheathed by PN or neurons without PN, sections were processed for one of
these detection methods for degenerating neurons in combination with antibodies
against aggrecan core protein (HAG7D4, mouse-anti-human aggrecan, 1 : 10,
AbD Serotec, Düsseldorf, Germany) combined with biotinylated NeuN (mouse-
anti-NeuN clone A60, ab77315, 1 : 100, Millipore) or biotinylated WFA, 1 : 100,
Sigma, Taufkirchen, Germany ) combined with NeuN (mouse-anti-NeuN clone A60
MAB 377, 1 : 100, Millipore). Fluoro-Jade B as anionic dye specifically stains
degenerating neurons by binding to a currently unknown, most likely a poly-amine,
basic substance in the neuron.59,60 For counting procedures, Fluoro-Jade B was
chosen because of its high technical feasibility and reproducibility. To evaluate a
potential contribution of PV to the neuroprotective properties of the PNs, sections
were also stained with an antibody against PV (PV25, 1 : 500, Swant, Marly,
Switzerland) in combination with WFA and Fluoro-Jade B as well as HAG and
Fluoro-Jade B.
Briefly, sections were washed in PBS, and preincubated in a blocking solution
(2% bovine serum albumin, 0.3% casein, 0.5% donkey normal serum) for 1 h
followed by 48 h incubation with the primary antibodies at 4 1C. After washing,
sections were incubated with Cy3-conjugated donkey-anti-mouse IgG (1 : 300,
Dianova, Hamburg, Germany) or Cy3-conjugated donkey-anti-rabbit IgG (1 : 300,
Dianova) and Cy5-conjugated streptavidin (1 : 150, Dianova) for 3 h. Sections were
washed, mounted on gelatine-coated slides and incubated with 0.001% Fluoro-Jade
in 0.1% acetic acid for 30 min. Slides were washed with distilled water, placed onto a
slide warmer until fully dry, immersed in xylene for 3 min and coverslipped using
DePeX (Serva, Heidelberg, Germany). Furthermore, combining anti-caspase-3 or
anti-H2AX with WFA and NeuN requires incubation with Cy2-conjugated donkey-
anti-rabbit IgG (1 : 250, Dianova), Cy3-conjugated streptavidin (1 : 300, Dianova)
and Cy5-conjugated donkey-anti-mouse IgG (1 : 100, Dianova). Here, sections were
washed, mounted on gelatine coated slides and coverslipped with Entellan (MercK,
Darmstadt, Germany).
Quantification of degeneration. The extent of degeneration was
examined after Fluoro-Jade B staining. For quantification of cell death, the
cross-sectional tissue area covered by degenerated cells, identified after Fluoro-
Jade B staining, was determined on serial sections cut throughout the entire
extension of the lesion at an interval of 120mm. For each animal, the largest
cross-sectional area was defined as region of interest (ROI) and copied to all
Figure 8 Illustration of the evaluation method. (a) For the quantification
of neuronal death after injection of 0.2ml FeCl3 (white arrow assigns point of
injection) the largest cross-sectional area covered by Fluoro-Jade B-positive cells
was defined as reference area (white circle) and copied to all analysed sections.
Within this area, counting of Fluoro-Jade B-positive neurons was performed within
three rectangles of a size of 0.18 mm2, randomly placed to the reference area (b).
Scale bar 500mm
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sections (Figure 8a). Fluoro-Jade B-positive neurons (detected by NeuN) were
counted within three rectangles of a cross-sectional area of 0.18 mm2, randomly
placed to the ROI (Figure 8b).Counts were performed using the optical fractionator
method8 on a Zeiss (Jena, Germany) Axioskop 2 plus microscope equipped with a
motorized stage (Märzhäuser, Wetzlar, Germany), a Ludl MAC 5000 (LEP,
Hawthorne, NY, USA) and a digital camera CX 9000 (MicroBrightField, Williston,
VT, USA). Stereo Investigator software 6 (MicroBrightField) was used to analyse
serial sections (19mm thick). Statistical analyses were performed by Mann–
Whitney test and Wilcoxon rank test.
Determination of numerical neuronal density. To evaluate the
potential effects of knockout genotypes on the numerical density of neurons
associated with PN, as well as on PV immunoreactive neurons, frontal brain sections
of all mouse strains were investigated. The contralateral brain area of the injection
site was used as internal control and analysed by using the optical fractionator
method, too. Counting procedures were performed in the defined ROI as described
above. Statistical analyses were done by Mann–Whitney Test.
Sample preparation for SDS-PAGE. For this analysis, mice received
an injection of 0.2ml 20 mM FeCl3 into the barrel field as described previously.
Twenty-four hours after injection, mice were deeply anaesthetized by CO2,
decapitated, their brains removed and immediately frozen in liquid nitrogen. On a
dry ice-cooled worktop, the frozen brain was dissected in 2 mm thick frontal
sections. The slice displaying the strongest lesion was picked, bisected and
transferred (separated by an injected and control hemisphere) to 2-ml tubes.
Then, hemisphere sections were homogenized on ice, using an Ultra-Turrax tube
drive (IKA), in homogenization buffer (0.02 M Tris-HCl, 0.15 M NaCl, 5 mM NaF,
1 mM Na3VO4, 2 mM MgCl2, pH 7.4) containing a protease inhibitor (Complete,
Roche, Mannheim, Germany). The homogenate was centrifuged at 10 000 g for
14 min at 4 1C, followed by determination of the protein concentration in the
supernatant by using the BCA Assay.
To evaluate the content of aggrecan, the main proteoglycan component of the
PN, the single supernatant was digested with 0.25 U Chondroitinase ABC (Sigma-
Aldrich, Hamburg, Germany) at 37 1C for 3 h to erase sulphated GAG side chains of
the proteoglycan core protein, according to Matthews et al.44
Electrophoresis and western blotting. To run the SDS page, the
volume of the supernatant containing 30 mg protein was added to the same
volume of 1 SDS sample buffer and denaturized at 75 1C for 15 min. Then the
samples were subjected to electrophoresis on 6% SDS-polyacrylamide gels with a
4.3% stacking gel and transferred to a poly vinylidene difluoride membrane (Perkin
Elmer, Rodgau, Germany). The membrane was probed with anti-aggrecan
(AB1031, 1 : 0000, Millipore) and anti-HSP 90 (4874, 1 : 1000, Cell Signaling,
Beverly, MA, USA) antibodies and finally detected with an enhanced
chemiluminescence western blot system (DNR Bio-Imaging systems, Biostep,
Jahnsdorf, Germany). The blots were scanned and the ratios of optical band
intensities of aggrecan normalized to HSP 90 were calculated using TINA
software. Experiments were done in duplicates.
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